Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Long-Term Debt in Other Currencies by Year
Long-Term Debt in Other Currencies ($M)
Novartis Long-Term Debt in Other Currencies: $164M in FY2025, up 397.0% from a year earlier.
Latest, FY2025
164
Period ended Dec 31, 2025
Change on a year earlier
+397.0%
33 in FY2024
History
6 years
Since FY2020
Sources
5
Documents cited below
Where the FY2025 figure comes from
Source: Novartis Form 20-F (0001114448-26-000004) ↗
Reported in Form 20-F Note 19.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Long-Term Debt in Other Currencies ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 164 | +397.0% | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2024 | Dec 31, 2024 | 33 | -19.5% | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2023 | Dec 31, 2023 | 41 | -38.8% | Novartis Form 20-F (0001370368-25-000004) ↗ |
| FY2022 | Dec 31, 2022 | 67 | +28.8% | Novartis Form 20-F (0001370368-24-000004) ↗ |
| FY2021 | Dec 31, 2021 | 52 | +36.8% | Novartis Form 20-F/A (0001370368-23-000048) ↗ |
| FY2020 | Dec 31, 2020 | 38 | – | Novartis Form 20-F (0001370368-22-000010) ↗ |
Cite this data
StockData. (2026). Novartis Long-Term Debt in Other Currencies ($M), annual FY2020–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/debt-by-currency-other
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.